BioSpace News Archive

Incyte (Nasdaq:INCY) today announced that the first patient has been treated in the Phase 3 TRuE-AD clinical trial program evaluating the long-term safety and efficacy of ruxolitinib cream as monotherapy for adolescent and adult patients (age ≥ 12 years) with atopic dermatitis (AD) who are candidates for topical therapy.

The Board of Directors and staff of the Lupus Research Alliance mourn the death of Stephen Katz, MD, PhD, a true champion for the lupus community.

Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) today provides a full update on the savolitinib development programs in both lung cancer and kidney cancer.

INmune Bio Inc., an immunotherapy company developing treatments to reprogram the innate immune system to fight disease, announced today that it has been granted Clinical Trial Authorization (CTA) by the United Kingdom (UK) regulatory authority, Medicines and Healthcare products Regulatory Agency (MHRA), for a Phase I clinical trial of its lead therapeutic candidate INKmune

The prospect of an actively personalized approach to the treatment of glioblastoma has moved a step closer with the recent publication in Natureof favorable data from the phase 1 study GAPVAC-101, testing a novel therapeutic concept tailored to specific characteristics of patients’ individual tumors and immune systems

SAB Biotherapeutics, Inc. announced today, that it has raised $22 million in its Series A-2 round that closed December 15, 2018.

Blistering takedown of pharma greed by Foxhound Productions and produced by AHF is now live on two popular streaming services as it finishes weeklong theatrical run in L.A.

Coordinates ‘Give More’ oral health drive resulting in the donation of hundreds of goodie bags combining coupons for free cleanings, toothbrushes, oral hygiene products, and more for children ranging in ages from 3 to 11 years old

OSF HealthCare, the University of Illinois System, Illinois Central College, and the Greater Peoria Economic Development Council are joining forces to develop a Peoria Innovation Hub.